BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  DURECT Corporation Reports Second Quarter 2022 Financial Results and Update of Programs

  DURECT Corporation announced financial results for the three months ended June 30, 2022 and provided a corporate update.

  August 4, 2022

   · 

  11 min read
• Business

  Natera Reports Second Quarter 2022 Financial Results

  Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the second quarter ended June 30, 2022 and provided an update on recent business progress and financial outlook.

  August 4, 2022

   · 

  13 min read
• Business

  Nu Skin Enterprises Reports Second Quarter Financial Results

  Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second quarter 2022 results.

  August 4, 2022

   · 

  16 min read
• Business

  Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)

  Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced financial results for the three months ended June 30, 2022.

  August 4, 2022

   · 

  14 min read
• Genetown

  Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 04, 2022

  Syros Pharmaceuticals announced the grant of a restricted stock unit award for 31,000 shares of Syros common stock to one newly hired employee in connection with the employee’s commencement of employment with Syros.

  August 4, 2022

   · 

  1 min read
• Business

  Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board

  Legend Biotech Corporation announced the appointment of three new directors to its Board: Mr. Tomas Heyman as Class I director of Legend Biotech, Dr. Fangliang “Frank” Zhang as Class II director of Legend Biotech, and Dr. Li Mao as Class III director of Legend Biotech.

  August 4, 2022

   · 

  5 min read
• Business

  Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range

  Cerus Corporation announced financial results for the second quarter ended June 30, 2022.

  August 4, 2022

   · 

  18 min read
• Business

  Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results

  Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and second quarter 2022 financial results.

  August 4, 2022

   · 

  14 min read
• Business

  Globus Medical Reports Second Quarter 2022 Results

  Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended June 30, 2022.

  August 4, 2022

   · 

  17 min read
• Business

  CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

  CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today reported second quarter 2022 financial results and provided a business update.

  August 4, 2022

   · 

  13 min read